Driehaus Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-348,772
Closed -$6.19M 433
2025
Q1
$6.19M Sell
348,772
-339,623
-49% -$7.31M 0.06% 287
2024
Q4
$14.7M Sell
688,395
-216,986
-24% -$5.28M 0.12% 202
2024
Q3
$28.3M Buy
905,381
+721,768
+393% +$18M 0.24% 131
2024
Q2
$2.85M Buy
+183,613
New +$2.22M 0.03% 282
2021
Q3
Sell
-168,914
Closed -$15.5M 399
2021
Q2
$15.5M Buy
+168,914
New +$13.4M 0.2% 154
2019
Q3
Sell
-771,641
Closed -$27.8M 492
2019
Q2
$27.8M Buy
771,641
+5,729
+0.7% +$183K 0.87% 20
2019
Q1
$24.1M Buy
765,912
+12,063
+2% +$351K 0.91% 22
2018
Q4
$19M Buy
753,849
+41,528
+6% +$1.07M 0.81% 26
2018
Q3
$20.6M Buy
712,321
+313,706
+79% +$5.87M 0.63% 30
2018
Q2
$4.88M Buy
+398,615
New +$4.57M 0.16% 175

Other funds holding CDNA

Driehaus Capital Management's CDNA Position: Q2 2025 in Review

Driehaus Capital Management sold out of CareDx (CDNA) in Q2 2025, closing a stake of 348,772 shares — an estimated $6.19M sold.

Driehaus Capital Management first reported a position in CDNA in Q2 2018 and held it in 10 quarters. The position peaked at $28.3M in Q3 2024. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Driehaus Capital Management reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 348,772 CareDx shares in Q2 2025, an estimated $6.19M.
  • Driehaus Capital Management first reported a position in CareDx in Q2 2018 and held it in 10 quarters.
  • Driehaus Capital Management's CareDx position peaked at $28.3M in Q3 2024.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Driehaus Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.